KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $5,013,000 | -25.5% | 109,199 | 0.0% | 5.09% | -8.2% |
Q4 2015 | $6,729,000 | -13.2% | 109,199 | -21.6% | 5.54% | +15.8% |
Q3 2015 | $7,752,000 | -29.1% | 139,225 | -22.3% | 4.78% | +91.2% |
Q2 2015 | $10,927,000 | +5.7% | 179,225 | 0.0% | 2.50% | -9.6% |
Q1 2015 | $10,338,000 | -62.4% | 179,225 | -62.4% | 2.77% | -45.5% |
Q4 2014 | $27,483,000 | – | 476,563 | – | 5.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |